The 2nd September issue of the journal Molecular Cell has published a discovery that opens the door for the development of more effective treatment strategies for aggressive breast cancers associated with EZH2, an enzyme that promotes the estrogen receptor-negative aggressive breast cancer, which remains unresponsive to current treatment strategies...
More...